Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The lanthionine synthetase C-like (LanCL) protein family in eukaryotes is homologous to the prokaryotic LanC enzymes, which are involved in lantibiotic biosynthesis. In humans, three main members have been identified: LanCL1, LanCL2, and LanCL3. While their precise biochemical functions remain incompletely understood, these proteins are increasingly recognized for their roles in cellular signaling and regulation, particularly in Akt/mTOR pathways and antioxidant responses. Abscisic acid (ABA) has been identified as a ligand for LANCL2, opening potential therapeutic avenues.
Modulation of Akt/mTOR signaling pathway; modulation of CBS activity; binding to glutathione
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lanthionine Synthetase C-like Protein Family (LanCL).